Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 70

1.

Managing chronic myeloid leukemia for treatment-free remission: a proposal from the GIMEMA CML WP.

Baccarani M, Abruzzese E, Accurso V, Albano F, Annunziata M, Barulli S, Beltrami G, Bergamaschi M, Binotto G, Bocchia M, Caocci G, Capodanno I, Cavazzini F, Cedrone M, Cerrano M, Crugnola M, D'Adda M, Elena C, Fava C, Fazi P, Fozza C, Galimberti S, Giai V, Gozzini A, Gugliotta G, Iurlo A, La Barba G, Levato L, Lucchesi A, Luciano L, Lunghi F, Lunghi M, Malagola M, Marasca R, Martino B, Melpignano A, Miggiano MC, Montefusco E, Musolino C, Palmieri F, Pregno P, Rapezzi D, Rege-Cambrin G, Rupoli S, Salvucci M, Sancetta R, Sica S, Spadano R, Stagno F, Tiribelli M, Tomassetti S, Trabacchi E, Bonifacio M, Breccia M, Castagnetti F, Pane F, Russo D, Saglio G, Soverini S, Vigneri P, Rosti G.

Blood Adv. 2019 Dec 23;3(24):4280-4290. doi: 10.1182/bloodadvances.2019000865.

2.

Real-life use of phototherapy in early-stage mycosis fungoides from the Cutaneous Lymphoma Commission of the Italian Lymphoma Foundation: results of a web-based survey.

Grandi V, Fava P, Rupoli S, Alberti Violetti S, Canafoglia L, Berti E, Quaglino P, Pimpinelli N; Italian Lymphoma Foundation.

G Ital Dermatol Venereol. 2018 Oct;153(5):745-746. doi: 10.23736/S0392-0488.17.05693-0. Epub 2017 Nov 16. No abstract available.

PMID:
29144101
3.

Standardization of regimens in Narrowband UVB and PUVA in early stage mycosis fungoides: position paper from the Italian Task Force for Cutaneous Lymphomas.

Grandi V, Fava P, Rupoli S, Alberti Violetti S, Canafoglia L, Quaglino P, Berti E, Pimpinelli N; Cutaneous Lymphoma Task Force (Commissione Linfomi Cutanei) of Lymphoma Italian Foundation (Fondazione Italiana Linfomi, FIL).

J Eur Acad Dermatol Venereol. 2018 May;32(5):683-691. doi: 10.1111/jdv.14668. Epub 2018 Jan 29. Review.

PMID:
29105200
4.

The BCR-ABL1 transcript type influences response and outcome in Philadelphia chromosome-positive chronic myeloid leukemia patients treated frontline with imatinib.

Castagnetti F, Gugliotta G, Breccia M, Iurlo A, Levato L, Albano F, Vigneri P, Abruzzese E, Rossi G, Rupoli S, Cavazzini F, Martino B, Orlandi E, Pregno P, Annunziata M, Usala E, Tiribelli M, Sica S, Bonifacio M, Fava C, Gherlinzoni F, Bocchia M, Soverini S, Bochicchio MT, Cavo M, Giovanni M, Saglio G, Pane F, Baccarani M, Rosti G; GIMEMA CML Working Party.

Am J Hematol. 2017 Aug;92(8):797-805. doi: 10.1002/ajh.24774. Epub 2017 May 30.

5.

Primary cutaneous B-cell lymphoma other than marginal zone: clinicopathologic analysis of 161 cases: Comparison with current classification and definition of prognostic markers.

Lucioni M, Berti E, Arcaini L, Croci GA, Maffi A, Klersy C, Goteri G, Tomasini C, Quaglino P, Riboni R, Arra M, Dallera E, Grandi V, Alaibac M, Ramponi A, Rattotti S, Cabras MG, Franceschetti S, Fraternali-Orcioni G, Zerbinati N, Onida F, Ascani S, Fierro MT, Rupoli S, Gambacorta M, Zinzani PL, Pimpinelli N, Santucci M, Paulli M.

Cancer Med. 2016 Oct;5(10):2740-2755. doi: 10.1002/cam4.865. Epub 2016 Sep 26.

6.

Unbiased pro-thrombotic features at diagnosis in 977 thrombocythemic patients with Philadelphia-negative chronic myeloproliferative neoplasms.

Gugliotta L, Iurlo A, Gugliotta G, Tieghi A, Specchia G, Gaidano G, Scalzulli PR, Rumi E, Dragani A, Martinelli V, Santoro C, Randi ML, Tagariello G, Candoni A, Cattaneo D, Ricco A, Palmieri R, Liberati MA, Langella M, Rago A, Bergamaschi M, Monari P, Miglio R, Santoro U, Cacciola R, Rupoli S, Mastrullo L, Musto P, Mazzucconi MG, Vignetti M, Cortelezzi A, Vianelli N, Martino B, De Stefano V, Passamonti F, Vannucchi AM; Registro Italiano Trombocitemie RIT.

Leuk Res. 2016 Jul;46:18-25. doi: 10.1016/j.leukres.2016.04.004. Epub 2016 Apr 7.

PMID:
27107744
7.

Results of a prospective phase II trial with oral low-dose bexarotene plus photochemotherapy (PUVA) in refractory and/or relapsed patients with mycosis fungoides.

Rupoli S, Canafoglia L, Goteri G, Leoni P, Brandozzi G, Federici I, Micucci G, Giantomassi F, Mozzicafreddo G, Alterini R, Filosa G, Ricotti G, Simonacci M, Scortechini AR, Zizzi A, Pimpinelli N.

Eur J Dermatol. 2016 Jan-Feb;26(1):13-20. doi: 10.1684/ejd.2015.2672.

PMID:
26678311
8.

Recurrent Thrombotic Events after Discontinuation of Vitamin K Antagonist Treatment for Splanchnic Vein Thrombosis: A Multicenter Retrospective Cohort Study.

Riva N, Ageno W, Poli D, Testa S, Rupoli S, Santoro R, Lerede T, Piana A, Carpenedo M, Nicolini A, Ferrini PM, Martini G, Mangione C, Contino L, Bonfanti C, Gresele P, Tosetto A.

Gastroenterol Res Pract. 2015;2015:620217. doi: 10.1155/2015/620217. Epub 2015 Oct 5.

9.

Thrombosis in essential thrombocytemia and early/prefibrotic primary myelofibrosis: the role of the WHO histological diagnosis.

Rupoli S, Goteri G, Picardi P, Micucci G, Canafoglia L, Scortechini AR, Federici I, Giantomassi F, Da Lio L, Zizzi A, Honorati E, Leoni P.

Diagn Pathol. 2015 Apr 16;10:29. doi: 10.1186/s13000-015-0269-1.

10.

Safety of vitamin K antagonist treatment for splanchnic vein thrombosis: a multicenter cohort study.

Riva N, Ageno W, Poli D, Testa S, Rupoli S, Santoro R, Lerede T, Piana A, Carpenedo M, Nicolini A, Ferrini PM, Tosetto A; Italian Federation of Anticoagulation Clinics (FCSA); Italian Federation of Anticoagulation Clinics FCSA.

J Thromb Haemost. 2015 Jun;13(6):1019-27. doi: 10.1111/jth.12930. Epub 2015 May 13.

11.

Cerebral vein thrombosis in patients with Philadelphia-negative myeloproliferative neoplasms. An European Leukemia Net study.

Martinelli I, De Stefano V, Carobbio A, Randi ML, Santarossa C, Rambaldi A, Finazzi MC, Cervantes F, Arellano-Rodrigo E, Rupoli S, Canafoglia L, Tieghi A, Facchini L, Betti S, Vannucchi AM, Pieri L, Cacciola R, Cacciola E, Cortelezzi A, Iurlo A, Pogliani EM, Elli EM, Spadea A, Barbui T.

Am J Hematol. 2014 Nov;89(11):E200-5. doi: 10.1002/ajh.23809. Epub 2014 Jul 31.

12.

Mobilization-driven postconsolidation therapy in elderly patients with acute myeloid leukemia: feasibility and efficacy of autologous stem cell transplantation versus low-dose gemtuzumab ozogamicin.

Capelli D, Chiarucci M, Poloni A, Saraceni F, Mancini G, Trappolini S, Troiani E, Montanari M, Scortechini I, Offidani M, Rupoli S, Scortechini AR, Gini G, Discepoli G, Leoni P, Olivieri A.

Biol Blood Marrow Transplant. 2014 Sep;20(9):1399-406. doi: 10.1016/j.bbmt.2014.05.019. Epub 2014 May 28.

13.

Combination treatment in CTCL: the current role of bexarotene.

Delfino C, Grandi V, Pileri A, Rupoli S, Quaglino P, Alterini R, Goteri G, Canafoglia L, Pimpinelli N.

G Ital Dermatol Venereol. 2012 Dec;147(6):573-80.

PMID:
23149703
14.

Mycosis fungoides: disease evolution of the "lion queen" revisited.

Quaglino P, Pimpinelli N, Berti E, Calzavara-Pinton P, Lombardo GA, Rupoli S, Alaibac M, Arcaini L, Bagnato S, Baldo A, Bottoni U, Carbone A, Cestari R Clerico R, De Renzo A, Fava P, Fierro MT, Filotico R, Fimiani M, Frontani M Girgenti V, Goteri G, Leali C, Mamusa AM, Mariotti G, Mastrandrea V, Pellegrini C, Pennese E, Pileri A, Savoia P, Stelitano C, Titli S, Virgili A, Zichichi L, Zinzani PL, Bernengo MG.

G Ital Dermatol Venereol. 2012 Dec;147(6):523-31. Review.

PMID:
23149698
15.

Time course, clinical pathways, and long-term hazards risk trends of disease progression in patients with classic mycosis fungoides: a multicenter, retrospective follow-up study from the Italian Group of Cutaneous Lymphomas.

Quaglino P, Pimpinelli N, Berti E, Calzavara-Pinton P, Alfonso Lombardo G, Rupoli S, Alaibac M, Bottoni U, Carbone A, Fava P, Fimiani M, Mamusa AM, Titli S, Zinzani PL, Bernengo MG; Gruppo Italiano Linfomi Cutanei.

Cancer. 2012 Dec 1;118(23):5830-9. doi: 10.1002/cncr.27627. Epub 2012 Jun 6.

16.

Serum and tissue CTACK/CCL27 chemokine levels in early mycosis fungoides may be correlated with disease-free survival following treatment with interferon alfa and psoralen plus ultraviolet A therapy.

Goteri G, Rupoli S, Campanati A, Zizzi A, Picardi P, Cardelli M, Giantomassi F, Canafoglia L, Marchegiani F, Mozzicafreddo G, Brandozzi G, Stramazzotti D, Ganzetti G, Lisa R, Simonetti O, Offidani A, Federici I, Filosa G, Leoni P.

Br J Dermatol. 2012 May;166(5):948-52. doi: 10.1111/j.1365-2133.2012.10818.x.

PMID:
22233400
17.

GIMEMA AIDA 0493 amended protocol for elderly patients with acute promyelocytic leukaemia. Long-term results and prognostic factors.

Latagliata R, Breccia M, Fazi P, Vignetti M, Di Raimondo F, Sborgia M, Vincelli D, Candoni A, Salvi F, Rupoli S, Martinelli G, Kropp MG, Tonso A, Venditti A, Melillo L, Cimino G, Petti MC, Avvisati G, Lo-Coco F, Mandelli F; GIMEMA Acute Leukaemia Working Party.

Br J Haematol. 2011 Sep;154(5):564-8. doi: 10.1111/j.1365-2141.2011.08593.x. Epub 2011 Jul 14.

PMID:
21751984
18.

Frontline imatinib treatment of chronic myeloid leukemia: no impact of age on outcome, a survey by the GIMEMA CML Working Party.

Gugliotta G, Castagnetti F, Palandri F, Breccia M, Intermesoli T, Capucci A, Martino B, Pregno P, Rupoli S, Ferrero D, Gherlinzoni F, Montefusco E, Bocchia M, Tiribelli M, Pierri I, Grifoni F, Marzocchi G, Amabile M, Testoni N, Martinelli G, Alimena G, Pane F, Saglio G, Baccarani M, Rosti G; Gruppo Italiano Malattie Ematologiche dell'Adulto CML Working Party.

Blood. 2011 May 26;117(21):5591-9. doi: 10.1182/blood-2010-12-324228. Epub 2011 Mar 30.

PMID:
21450900
19.

[Neuropsychological modifications at high altitude: from Pamir to Karakorum].

Nardi B, Brandoni M, Capecci I, Castellani S, Rupoli S, Bellantuono C.

Riv Psichiatr. 2009 Jan-Feb;44(1):36-44. Italian.

PMID:
20066936
20.

Lesional skin chemokine CTACK/CCL27 expression in mycosis fungoides and disease control by IFN-alpha and PUVA therapy.

Goteri G, Rupoli S, Campanati A, Costagliola A, Sabato S, Stramazzotti D, Picardi P, Canafoglia L, Pulini S, Ganzetti G, Offidani AM, Leoni P.

Am J Transl Res. 2009 Jan 31;1(2):203-10.

21.

Efficacy and safety of pegylated liposomal doxorubicin in primary cutaneous B-cell lymphomas and comparison with the commonly used therapies.

Pulini S, Rupoli S, Goteri G, Pimpinelli N, Alterini R, Bettacchi A, Mulattieri S, Picardi P, Tassetti A, Scortechini AR, Fioritoni G, Leoni P.

Eur J Haematol. 2009 Mar;82(3):184-93. doi: 10.1111/j.1600-0609.2008.01197.x.

PMID:
19215609
22.

Diffuse large B-cell lymphoma with Homer-Wright rosettes, sinusoidal growth pattern, and CD30 expression: a possible overlap between microvillous lymphomas and sinusoidal CD30-positive large B-cell lymphomas.

Goteri G, Costagliola A, Tassetti A, Stramazzotti D, Morroni M, Rupoli S, Centurioni R, Leoni P.

Pathol Res Pract. 2009;205(4):279-82. doi: 10.1016/j.prp.2008.10.008. Epub 2008 Dec 6.

PMID:
19059735
23.

Prognostic markers in mycosis fungoides.

Goteri G, Rupoli S, Pulini S, Tassetti A, Leoni P.

Anal Quant Cytol Histol. 2008 Aug;30(4):187-9. No abstract available.

PMID:
18773735
24.

Time-Dependent Kinetics of Tretinoin in Chronic Myelogenous Leukaemia during Intermittent Dose Scheduling: 1 Week On/1 Week Off.

Regazzi MB, Russo D, Iacona I, Sacchi S, Visani G, Lazzarino M, Avvisati G, Pelicci PG, Dastoli G, Grandi C, Spreafico S, Grattoni R, Galieni P, Rupoli S, Maiolo AM, Guerra E, Liberati AM.

Clin Drug Investig. 1998;16(1):25-33.

PMID:
18370515
25.

Clinicopathological features of primary cutaneous B-cell lymphomas from an academic regional hospital in central Italy: no evidence of Borrelia burgdorferi association.

Goteri G, Ranaldi R, Simonetti O, Capretti R, Menzo S, Stramazzotti D, Morichetti D, Offidani AM, Rupoli S, Leoni P.

Leuk Lymphoma. 2007 Nov;48(11):2184-8.

PMID:
17926178
26.

Coexistence of two discordant B-cell lymphomas in the skin and lymph node: report of a case with primary cutaneous follicle-center lymphoma and nodal mantle-cell lymphoma.

Goteri G, Rupoli S, Stramazzotti D, Discepoli G, Scortechini AR, Giacchetti A, Morichetti D, Tassetti A, Pulini S, Mulattieri S, Stronati A, Leoni P.

Br J Dermatol. 2007 Sep;157(3):629-31. Epub 2007 Jun 26. No abstract available.

PMID:
17596170
27.

Pegylated liposomal doxorubicin in the treatment of primary cutaneous T-cell lymphomas.

Pulini S, Rupoli S, Goteri G, Pimpinelli N, Alterini R, Tassetti A, Scortechini AR, Offidani M, Mulattieri S, Stronati A, Brandozzi G, Giacchetti A, Mozzicafreddo G, Ricotti G, Filosa G, Bettacchi A, Simonacci M, Novelli N, Leoni P.

Haematologica. 2007 May;92(5):686-9.

28.

Differences in survivin location and Bcl-2 expression in CD30+ lymphoproliferative disorders of the skin compared with systemic anaplastic large cell lymphomas: an immunohistochemical study.

Goteri G, Simonetti O, Rupoli S, Piccinini G, Rubini C, Stramazzotti D, Fazioli F, Capomagi C, Leoni P, Offidani AM, Lo Muzio L.

Br J Dermatol. 2007 Jul;157(1):41-8. Epub 2007 May 2. Erratum in: Br J Dermatol. 2007 Aug;157(2):431. Lomuzio, L [corrected to Lo Muzio, L].

PMID:
17484779
29.

Severe diarrhoea during Campath-1H treatment for refractory cutaneous T-cell lymphoma.

Goteri G, Rupoli S, Tassetti A, Pulini S, Morichetti D, Filosa A, Mandolesi A, Veccia S, Leoni P, Bearzi I.

Ann Hematol. 2006 Sep;85(9):617-9. Epub 2006 Jul 4. No abstract available.

PMID:
16821018
30.

Thalidomide, dexamethasone, and pegylated liposomal doxorubicin (ThaDD) for patients older than 65 years with newly diagnosed multiple myeloma.

Offidani M, Corvatta L, Piersantelli MN, Visani G, Alesiani F, Brunori M, Galieni P, Catarini M, Burattini M, Centurioni R, Ferranti M, Rupoli S, Scortechini AR, Giuliodori L, Candela M, Capelli D, Montanari M, Olivieri A, Poloni A, Polloni C, Marconi M, Leoni P.

Blood. 2006 Oct 1;108(7):2159-64. Epub 2006 Jun 8.

PMID:
16763209
31.

Prognostic factors in primary cutaneous B-cell lymphoma: the Italian Study Group for Cutaneous Lymphomas.

Zinzani PL, Quaglino P, Pimpinelli N, Berti E, Baliva G, Rupoli S, Martelli M, Alaibac M, Borroni G, Chimenti S, Alterini R, Alinari L, Fierro MT, Cappello N, Pileri A, Soligo D, Paulli M, Pileri S, Santucci M, Bernengo MG; Italian Study Group for Cutaneous Lymphomas.

J Clin Oncol. 2006 Mar 20;24(9):1376-82. Epub 2006 Feb 21.

PMID:
16492713
32.

Low-dose thalidomide with pegylated liposomal doxorubicin and high-dose dexamethasone for relapsed/refractory multiple myeloma: a prospective, multicenter, phase II study.

Offidani M, Corvatta L, Marconi M, Visani G, Alesiani F, Brunori M, Galieni P, Catarini M, Burattini M, Centurioni R, Rupoli S, Scortechini AR, Giuliodori L, Candela M, Capelli D, Montanari M, Olivieri A, Piersantelli MN, Leoni P.

Haematologica. 2006 Jan;91(1):133-6.

33.

Gemcitabine as frontline treatment for cutaneous T-cell lymphoma: phase II study of 32 patients.

Marchi E, Alinari L, Tani M, Stefoni V, Pimpinelli N, Berti E, Pagano L, Bernengo MG, Zaja F, Rupoli S, Pileri S, Baccarani M, Zinzani PL.

Cancer. 2005 Dec 1;104(11):2437-41.

34.

Long-term experience with low-dose interferon-alpha and PUVA in the management of early mycosis fungoides.

Rupoli S, Goteri G, Pulini S, Filosa A, Tassetti A, Offidani M, Filosa G, Mozzicafreddo G, Giacchetti A, Brandozzi G, Cataldi I, Barulli S, Ranaldi R, Scortechini AR, Capretti R, Fabris G, Leoni P; Marche Regional Multicentric Study Group of Cutaneous Lymphomas.

Eur J Haematol. 2005 Aug;75(2):136-45.

PMID:
16000130
35.

Common and rare side-effects of low-dose thalidomide in multiple myeloma: focus on the dose-minimizing peripheral neuropathy.

Offidani M, Corvatta L, Marconi M, Malerba L, Mele A, Olivieri A, Brunori M, Catarini M, Candela M, Capelli D, Montanari M, Rupoli S, Leoni P.

Eur J Haematol. 2004 Jun;72(6):403-9.

PMID:
15128418
36.

Density of neoplastic lymphoid infiltrate, CD8+ T cells, and CD1a+ dendritic cells in mycosis fungoides.

Goteri G, Filosa A, Mannello B, Stramazzotti D, Rupoli S, Leoni P, Fabris G.

J Clin Pathol. 2003 Jun;56(6):453-8.

37.

Gemcitabine alone or combined with cisplatin in relapsed or refractory multiple myeloma.

Offidani M, Mele A, Corvatta L, Marconi M, Malerba L, Olivieri A, Rupoli S, Alesiani F, Leoni P.

Leuk Lymphoma. 2002 Jun;43(6):1273-9.

PMID:
12152996
38.

Clinical activity and safety of combination immunotherapy with IFN-alpha 2a and Rituximab in patients with relapsed low grade non-Hodgkin's lymphoma.

Sacchi S, Federico M, Vitolo U, Boccomini C, Vallisa D, Baldini L, Petrini M, Rupoli S, Di Raimondo F, Merli F, Liso V, Tabilio A, Saglio G, Vinci G, Brugiatelli M, Dastoli G; GISL.

Haematologica. 2001 Sep;86(9):951-8.

39.

A predictive model of varicella-zoster virus infection after autologous peripheral blood progenitor cell transplantation.

Offidani M, Corvatta L, Olivieri A, Mele A, Brunori M, Montanari M, Rupoli S, Scalari P, Leoni P.

Clin Infect Dis. 2001 May 15;32(10):1414-22. Epub 2001 Apr 18.

PMID:
11317241
40.

Diagnosis of essential thrombocythemia at platelet counts between 400 and 600x10(9)/L. Gruppo Italiano Malattie Mieloproliferative Croniche(GIMMC).

Sacchi S, Vinci G, Gugliotta L, Rupoli S, Gargantini L, Martinelli V, Baravelli S, Lazzarino M, Finazzi G.

Haematologica. 2000 May;85(5):492-5.

41.

Infectious complications after autologous peripheral blood progenitor cell transplantation followed by G-CSF.

Offidani M, Corvatta L, Olivieri A, Rupoli S, Frayfer J, Mele A, Manso E, Montanari M, Centurioni R, Leoni P.

Bone Marrow Transplant. 1999 Nov;24(10):1079-87.

42.

Low dose interferon-alpha2b combined with PUVA is an effective treatment of early stage mycosis fungoides: results of a multicenter study. Cutaneous-T Cell Lymphoma Multicenter Study Group.

Rupoli S, Barulli S, Guiducci B, Offidani M, Mozzicafreddo G, Simonacci M, Filosa G, Giacchetti A, Ricotti G, Brandozzi G, Cataldi I, Serresi S, Ceschini R, Bugatti L, Offidani A, Giangiacomi M, Brancorsini D, Leoni P.

Haematologica. 1999 Sep;84(9):809-13.

43.

Expression of c-myb and B-myb oncogenes on myelofibrotic marrow fibroblasts.

Scortechini AR, Rupoli S, Piccinini G, Luchetti MM, Cantori I, Gabrielli A, Leoni P.

Leuk Lymphoma. 1999 Apr;33(3-4):295-304. Erratum in: Leuk Lymphoma 1999 Sep;35(1-2):following 2.

PMID:
10221509
44.

The Italian Consensus Conference on Diagnostic Criteria for Myelofibrosis with Myeloid Metaplasia.

Barosi G, Ambrosetti A, Finelli C, Grossi A, Leoni P, Liberato NL, Petti MC, Pogliani E, Ricetti M, Rupoli S, Visani G, Tura S.

Br J Haematol. 1999 Mar;104(4):730-7. Review.

PMID:
10192432
45.

Splenectomy and risk of blast transformation in myelofibrosis with myeloid metaplasia. Italian Cooperative Study Group on Myeloid with Myeloid Metaplasia.

Barosi G, Ambrosetti A, Centra A, Falcone A, Finelli C, Foa P, Grossi A, Guarnone R, Rupoli S, Luciano L, Petti MC, Pogliani E, Russo D, Ruggeri M, Quaglini S.

Blood. 1998 May 15;91(10):3630-6.

PMID:
9572998
46.

Two dosage interferon-alpha 2b maintenance therapy in patients affected by low-risk multiple myeloma in plateau phase: a randomized trial.

Offidani M, Olivieri A, Montillo M, Rupoli S, Centurioni R, Alesiani F, Marchegiani G, Pieroni S, Catarini M, Pelliccia G, Altilia F, Leoni P.

Haematologica. 1998 Jan;83(1):40-7.

47.

All-trans retinoic acid (ATRA) in patients with chronic myeloid leukemia in the chronic phase.

Russo D, Regazzi M, Sacchi S, Visani G, Lazzarino M, Avvisati G, Pelicci PG, Dastoli G, Grandi C, Iacona I, Candoni A, Grattoni R, Galieni P, Rupoli S, Liberati AM, Maiolo AT.

Leukemia. 1998 Apr;12(4):449-54.

48.

Alfa-interferon in the treatment of essential thrombocythemia: clinical results and evaluation of its biological effects on the hematopoietic neoplastic clone. Italian Cooperative Group on ET.

Sacchi S, Gugliotta L, Papineschi F, Liberati AM, Rupoli S, Delfini C, Ruggeri M, Cavanna L, Bucalossi A, Benedetti E, Ferrandina C, Vinci G, Morselli M, Torelli G.

Leukemia. 1998 Mar;12(3):289-94.

49.

Direct demonstration of cytokeratin filaments by electron microscopy in K562 cell lines in liquid culture.

Mancini S, Olivieri A, Masia MC, Ombrosi L, Montanari M, Rupoli S, Curzi L, Morroni M, Sisti S, Leoni P.

Boll Soc Ital Biol Sper. 1997 May-Jun;73(5-6):77-83.

PMID:
9796125
50.

[Biologic aspects and clinical use of granulocyte growth factor].

Rupoli S, Battelli N, Del Prete S, Salvi A, Cinciripini A, Scortechini AR, Cantori I, Barulli S, Leoni P.

Recenti Prog Med. 1995 Dec;86(12):510-7. Review. Italian.

PMID:
8588087

Supplemental Content

Loading ...
Support Center